Tokyo, Aug. 14 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000058773) titled 'Study of the relationship between FLT accumulation and thymine synthesis pathway in lung cancer using PET imaging' on Aug. 12.
Study Type:
Observational
Primary Sponsor:
Institute - University of Fukui
Condition:
Condition - Non-small cell lung cancer
Classification by malignancy - Malignancy
Genomic information - NO
Objective:
Narrative objectives1 - The purpose of this study is to evaluate the association between different FLT and FDG-PET findings and the activation of salvage and de novo pathways of the thymine synthesis pathway in tumors.
Basic objectives2 - Efficacy
Eligibility:
Age-lower limit - 18
years-old
<=
Age-upper limit - Not applicable
Gender - Male and Female
Key inclusion criteria - Patients with untreated non-small cell lung cancer confirmed by histological or cytological diagnosis, or with primary lung cancer strongly suspected by CT or FDG-PET imaging and scheduled for surgical resection.
Patients who have been fully informed about their participation in this study, and who have given written consent of their own free will based on a thorough understanding of the study.
Key exclusion criteria - 1) Pregnant woman
2) Patients with metalic device in their body
3) Patients with claustrophobia
4) Patients with a long diameter of less than 2 cm of the solid component of the primary lung cancer on CT
5) Other cases attending physician it is determined unsuitable for registration of the study
Target Size - 30
Recruitment Status:
Recruitment status - Open public recruiting
Date of protocol fixation - 2025 Year 07 Month 01 Day
Date of IRB - 2025 Year 05 Month 19 Day
Anticipated trial start date - 2025 Year 07 Month 01 Day
Last follow-up date - 2030 Year 03 Month 31 Day
To know more, visit https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000066731
Disclaimer: Curated by HT Syndication.
